While healthcare disparities have been noted for several decades, recent research has highlighted the role of technology in exacerbating these disparities. Embedded race corrections in medical devices and clinical decision support tools have been implicated in contributing to disparate outcomes by creating higher care thresholds for Black and nonwhite patients. Described as requiring patients to be “twice as sick,” these thresholds often delay diagnosis and treatment and limit insurance coverage. The COVID-19 pandemic has increased attention on disparities partly due to the role of devices such as the pulse oximeter and decision support algorithms such as SOFA play in guiding medical decisions, including rationing. Despite good faith efforts to create safe, usable medical technology using human-centered design processes and following applicable FDA guidelines, inequities induced or facilitated by these technologies remain. Given these biases in medical technology, equity should be considered a critical part of the design process as early as possible in the design process. In this talk I am going to present some ideas on how we incorporate equity considerations at the various stages of the design process. These changes can not only support health equity, but also lead to better, safer, and more accessible medical technology.